An expert explains what biliary tract cancers are and the current landscape of treatment as well as future advancements. In the treatment of newly diagnosed biliary tract cancer, the current standard ...

Bile duct cancer, also known as cholangiocarcinoma, forms in the thin tubes that carry bile from your liver to your gallbladder and small intestine. Though relatively rare, cholangiocarcinoma is often ...

Surgery for gallbladder cancer can be successful at removing cancer cells, particularly when doctors diagnose the cancer at an early stage and the person is in otherwise good health. Gallbladder ...

Gallbladder cancer is a relatively rare cancer that’s usually diagnosed in an advanced stage. Symptoms often don’t appear until the cancer grows large or spreads. The American Cancer Society estimates ...

There is an association between hepatitis B virus (HBV) infection and an increased risk of extrahepatic bile duct cancer. The extrahepatic bile duct collects bile from the liver, but is located ...

The influencer, 26, is currently in between stages of a clinical trial involving tumor-infiltrating lymphocyte therapy ...

Bile duct cancer can often be treated more effectively when detected early. However, its initial symptoms are often mild and can resemble common digestive or liver problems, leading to delayed ...

The results of a clinical trial led by researchers at the University of Arizona Health Sciences and published in the Journal of Clinical Oncology show that chemotherapy combining three different types ...

A recent study published in the journal Microorganisms explores the microbiome composition in patients with biliary tract cancer. Study: Interplay between the Human Microbiome and Biliary Tract Cancer ...

Zanidatamab-hrii received FDA accelerated approval for HER2-positive biliary tract cancer, showing a 52% objective response rate in the HERIZON-BTC-01 trial. Biliary tract cancers represent 3% of ...

The Korean Association for Cancer Chemotherapy Research (KCSG) unveiled the achievements of domestic multi-center clinical ...